Evolocumab
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Evolocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $2.0 billion on Evolocumab across 2.2 million claims for 460,000 beneficiaries.
Evolocumab is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $281.81 to $281.97 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$281.81 – $281.97
per ML
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing EVOLOCUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REPATHA 140 MG/ML SURECLICK | $281.9692 per ML | -0.01% |
REPATHA 140 MG/ML SURECLICK | $281.9692 per ML | -0.01% |
REPATHA 140 MG/ML SYRINGE | $281.8058 per ML | 0.00% |
REPATHA 140 MG/ML SYRINGE | $281.8058 per ML | 0.00% |
Frequently Asked Questions
What is Evolocumab used to treat?
Evolocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Evolocumab?
In 2024, Medicare Part D spent $2.0 billion on Evolocumab across 2.2 million claims for 460,000 beneficiaries.
How many Evolocumab products are on the market?
The Evolocumab drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Evolocumab?
NADAC reference prices for Evolocumab range from $281.8058 to $281.9692 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Evolocumab?
1 manufacturer lists Evolocumab in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4).
How has the price of Evolocumab changed recently?
Over the past 7 days, 0 Evolocumab NDCs rose and 2 fell, with a market-wide average change of -0.0%.